Drugs and Treatments
Innovative Approaches to Treating Pancreatic Cancer
Explore the latest advances in pancreatic cancer treatments, highlighting new targeted therapies and innovative approaches to enhance patient outcomes.
Drugs and Treatments
Drugs and Treatments
AD-SMART Trial: Revolutionizing the Search for Alzheimer’s Treatments
The AD-SMART initiative is changing how Alzheimer's treatments are tested, focusing on efficiency and repurposed medicines.
Drugs and Treatments
Analyzing GLP-1 Drugs: Innovations in Metabolism and Treatment
This article explores advancements in GLP-1 medications for obesity treatment, including implications for cognitive health and addiction therapy.
Drugs and Treatments
New Clinical Trial Aims to Expedite Alzheimer's Treatment Research
A UK-based trial is testing diabetes and ADHD medications for their potential benefits in Alzheimer's care.
Drugs and Treatments
Eli Lilly's Revenue Soars 39% Driven by Obesity Medications
Eli Lilly boosts revenue forecast to $91-$92 billion, fueled by demand for its obesity drugs Mounjaro and Zepbound.
Drugs and Treatments
Major Cuts in Cancer Drug Prices, Yet Some Remain High
Recent price regulations have significantly lowered costs of some cancer drugs, but many patented treatments remain expensive.
Drugs and Treatments
OpenAI's Orchestra Bio Acquisition: A New Era for Drug Development
OpenAI's recent acquisition of Orchestra Bio signals advancements in AI-assisted drug development, potentially speeding up research and improving treatments.
Drugs and Treatments
AI Analysis of 400,000 Posts Surfaces Side Effects Patients Report and Trials Did Not
An analysis of roughly 400,000 public forum posts written by people taking GLP-1 drugs has surfaced effects that feature little in the trial literature, including menstrual changes and…
Drugs and Treatments
Experimental Compound Strengthened Bones by Switching On a Little-Known Receptor
A compound called AP503 built bone and slowed bone loss in animals by activating GPR133, a cell-surface receptor that has drawn little attention in skeletal research until now.
Drugs and Treatments
Poop Pills Increase Peanut Tolerance in Small Trial
A small clinical trial suggests oral fecal microbiome transplantation (FMT), sometimes called “poop pills,” may raise peanut tolerance in some adults with peanut allergy, but the…
Drugs and Treatments
FDA Approves SIMTRIYO: First NDSRI for ADHD
The FDA has approved SIMTRIYO, a new daily extended-release tablet containing centanafadine, as a treatment option for attention deficit hyperactivity disorder (ADHD) in adults and…
Drugs and Treatments
FDA Clears OTC Tylenol–Naproxen Combo for Fast, Lasting Relief
The Food and Drug Administration has approved an over-the-counter combination pill that pairs acetaminophen (Tylenol) with naproxen sodium (Aleve).